Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, WC1N 3BG, London, UK.
Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, WC1N 1PJ, London, UK.
J Neuroinflammation. 2021 Apr 19;18(1):94. doi: 10.1186/s12974-021-02147-6.
Neuroinflammation may contribute to the pathogenesis of Huntington's disease, given evidence of activated microglia and elevated levels of inflammatory molecules in disease gene carriers, even those many years from symptom onset. We have shown previously that monocytes from Huntington's disease patients are hyper-reactive to stimulation in a manner dependent on their autonomous expression of the disease-causing mutant HTT protein. To date, however, whether human microglia are similarly hyper-responsive in a cell-autonomous manner has not been determined.
Microglial-like cells were derived from human pluripotent stem cells (PSCs) expressing mutant HTT containing varying polyglutamine lengths. These included lines that are otherwise isogenic, such that any observed differences can be attributed with certainty to the disease mutation itself. Analyses by quantitative PCR and immunofluorescence microscopy respectively of key genes and protein markers were undertaken to determine whether Huntington's disease PSCs differentiated normally to a microglial fate. The resultant cultures and their supernatants were then assessed by various biochemical assays and multiplex ELISAs for viability and responses to stimulation, including the release of pro-inflammatory cytokines and reactive oxygen species. Conditioned media were applied to PSC-derived striatal neurons, and vice versa, to determine the effects that the secretomes of each cell type might have on the other.
Human PSCs generated microglia successfully irrespective of the expression of mutant HTT. These cells, however, were hyper-reactive to stimulation in the production of pro-inflammatory cytokines such as IL-6 and TNFα. They also released elevated levels of reactive oxygen species that have neurotoxic potential. Accompanying such phenotypes, human Huntington's disease PSC-derived microglia showed increased levels of apoptosis and were more susceptible to exogenous stress. Such stress appeared to be induced by supernatants from human PSC-derived striatal neurons expressing mutant HTT with a long polyglutamine tract.
These studies show, for the first time, that human Huntington's disease PSC-derived microglia are hyper-reactive due to their autonomous expression of mutant HTT. This provides a cellular basis for the contribution that neuroinflammation might make to Huntington's disease pathogenesis.
神经炎症可能导致亨廷顿病的发病机制,因为在疾病基因携带者中存在激活的小胶质细胞和炎症分子水平升高的证据,即使在症状出现多年后也是如此。我们之前已经表明,亨廷顿病患者的单核细胞对外界刺激的反应过度,这种反应方式依赖于它们自主表达致病突变 HTT 蛋白。然而,到目前为止,人类小胶质细胞是否以细胞自主的方式表现出类似的高反应性尚未确定。
从小鼠多能干细胞(PSCs)中衍生出具有不同谷氨酸长度的突变 HTT 的类小胶质细胞样细胞。这些细胞系在其他方面是同基因的,因此任何观察到的差异都可以肯定归因于疾病突变本身。通过定量 PCR 和免疫荧光显微镜分别分析关键基因和蛋白标志物,以确定亨廷顿病 PSCs 是否正常分化为小胶质细胞命运。然后通过各种生化测定和多重 ELISA 评估所得培养物及其上清液的活力和对刺激的反应,包括促炎细胞因子和活性氧物质的释放。将条件培养基应用于 PSC 衍生的纹状体神经元,并反之亦然,以确定每种细胞类型的分泌组可能对另一种细胞类型产生的影响。
无论是否表达突变 HTT,人类 PSCs 均成功生成小胶质细胞。然而,这些细胞在产生促炎细胞因子(如 IL-6 和 TNFα)方面对外界刺激的反应过度。它们还释放出具有神经毒性潜力的高水平活性氧物质。伴随这些表型,人类亨廷顿病 PSC 衍生的小胶质细胞显示出更高水平的细胞凋亡,并且对外源性应激更敏感。这种应激似乎是由表达长聚谷氨酰胺链的突变 HTT 的人类 PSC 衍生纹状体神经元的上清液诱导的。
这些研究首次表明,人类亨廷顿病 PSC 衍生的小胶质细胞由于自主表达突变 HTT 而反应过度。这为神经炎症可能对亨廷顿病发病机制的贡献提供了细胞基础。